Page 15 - Slide 1
P. 15
Amgen Bone Health Mentoring Program
Monday, October 15, at 11:30am – 2:30pm ◼ Ruth Chris, Minneapolis, MN
FR0392 Odanacatib Improved Estimated Femoral
Strength in Postmenopausal Women - Results of a 2-
year Placebo-controlled Trial.
Keaveny T, Brixen K, Chapurlat R, et al.
Session: Welcome Reception and Plenary Poster
Session ◼ Friday , October 12, 05:45 PM - 07:00 PM ◼
Discovery Hall-Hall B/Minneapolis Convention Center
Abstract Information Additional Notes from
Poster/Presentation*
Results ▪ Results of this study indicates that ODN- Updated/Additional
facilitated increases in cortical bone mass Data, Key
is due to accural of bone mass at the Takeaways
endosteal envelope of the femoral neck.
Conclusions ▪ ODN improves overall proximal femoral
strength in part, by increasing cortical
Implications thickness and endosteal bone apposition
for Canadian along with integral and trabecular BMD at
the femoral neck.
Practice
Discussion Points, Key Takeaways
